NO894602D0 - Farmasoeytisk blanding inneholdende n-(3,4-dimetoksy-cinnamoyl)antranilsyre. - Google Patents

Farmasoeytisk blanding inneholdende n-(3,4-dimetoksy-cinnamoyl)antranilsyre.

Info

Publication number
NO894602D0
NO894602D0 NO894602A NO894602A NO894602D0 NO 894602 D0 NO894602 D0 NO 894602D0 NO 894602 A NO894602 A NO 894602A NO 894602 A NO894602 A NO 894602A NO 894602 D0 NO894602 D0 NO 894602D0
Authority
NO
Norway
Prior art keywords
dimetoxy
cinnamoyl
composition
mixture containing
pharmaceutical mixture
Prior art date
Application number
NO894602A
Other languages
English (en)
Other versions
NO176346B (no
NO176346C (no
NO894602L (no
Inventor
Tokihiko Yamamoto
Taihei Shibazaki
Yukiyoshi Ajisawa
Ryoji Yamamoto
Yukihiko Kinoshita
Original Assignee
Kissei Pharmaceutical
Nitten Ophtalmic Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13861211&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO894602(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kissei Pharmaceutical, Nitten Ophtalmic Research Inst filed Critical Kissei Pharmaceutical
Publication of NO894602D0 publication Critical patent/NO894602D0/no
Publication of NO894602L publication Critical patent/NO894602L/no
Publication of NO176346B publication Critical patent/NO176346B/no
Publication of NO176346C publication Critical patent/NO176346C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
NO894602A 1989-04-04 1989-11-17 Fremgangsmåte ved fremstilling av en flytende, vandig farmasöytisk blanding for öye- og/eller nasal administrasjon NO176346C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1085521A JPH07116029B2 (ja) 1989-04-04 1989-04-04 トラニラスト水溶液製剤

Publications (4)

Publication Number Publication Date
NO894602D0 true NO894602D0 (no) 1989-11-17
NO894602L NO894602L (no) 1990-10-05
NO176346B NO176346B (no) 1994-12-12
NO176346C NO176346C (no) 1995-03-22

Family

ID=13861211

Family Applications (1)

Application Number Title Priority Date Filing Date
NO894602A NO176346C (no) 1989-04-04 1989-11-17 Fremgangsmåte ved fremstilling av en flytende, vandig farmasöytisk blanding for öye- og/eller nasal administrasjon

Country Status (13)

Country Link
US (1) US5356620A (no)
EP (1) EP0391002B1 (no)
JP (1) JPH07116029B2 (no)
KR (1) KR940002660B1 (no)
AT (1) ATE103808T1 (no)
AU (1) AU623191B2 (no)
CA (1) CA2003190C (no)
DE (1) DE68914438T2 (no)
DK (1) DK555089A (no)
ES (1) ES2063146T3 (no)
FI (1) FI95773C (no)
HK (1) HK1003780A1 (no)
NO (1) NO176346C (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897858A (en) 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
PT974350E (pt) * 1996-02-07 2002-12-31 Lead Chem Co Ltd Preparacao contendo tranilast para aplicacao externa e metedo para a sua producao
JPH09278653A (ja) * 1996-04-05 1997-10-28 Santen Pharmaceut Co Ltd 網膜疾患治療剤
IL118657A0 (en) * 1996-06-14 1996-10-16 Arad Dorit Inhibitors for picornavirus proteases
KR100509421B1 (ko) * 1996-09-28 2005-08-22 깃세이 야쿠힌 고교 가부시키가이샤 각막 상피하 혼탁 억제제
EA001745B1 (ru) * 1996-10-14 2001-08-27 Киссеи Фармасьютикал Ко., Лтд. Ингибитор вторичной катаракты
IL131216A (en) * 1997-02-14 2003-10-31 Kissei Pharmaceutical Drugs inhibiting progress of pterygium and postoperative recurrence of the same
KR20010006485A (ko) * 1997-04-18 2001-01-26 간자와 무츠와 망막 색소상피세포의 과잉증식에 관한 질환의 예방 또는 치료제
IL122591A0 (en) 1997-12-14 1998-06-15 Arad Dorit Pharmaceutical compositions comprising cystein protease inhibitors
US6274626B1 (en) 1998-12-22 2001-08-14 Bausch & Lomb Incorporated Pheniramine-containing compositions and method for treating allergic responses
JP2001158750A (ja) * 1999-12-02 2001-06-12 Lion Corp 眼科用組成物及び抗アレルギー薬の持続性向上方法
JP4541504B2 (ja) * 2000-06-14 2010-09-08 沢井製薬株式会社 トラニラストまたはその薬理学的に許容される塩を有効成分として含有する安定な水溶液製剤
WO2002055454A2 (en) * 2001-01-10 2002-07-18 Smithkline Beecham Corporation Process and product
JP2011225626A (ja) * 2001-02-01 2011-11-10 Rohto Pharmaceutical Co Ltd 点眼剤
JP2002363075A (ja) * 2001-06-05 2002-12-18 Kao Corp 高血圧症予防・治療剤
DE10254872A1 (de) 2002-11-25 2004-06-03 Symrise Gmbh & Co. Kg Anthranilsäureamide und deren Derivate als kosmetische und pharmazeutische Wirkstoffe
JP2004189731A (ja) * 2002-11-26 2004-07-08 Taisho Pharmaceut Co Ltd 点鼻剤
US20050106230A1 (en) * 2003-11-17 2005-05-19 Young Janel E. Drug-enhanced adhesion prevention
JP2006306765A (ja) * 2005-04-27 2006-11-09 Nippon Tenganyaku Kenkyusho:Kk トラニラスト水性点眼液
EP2035369B1 (en) * 2006-07-05 2014-06-25 Fibrotech Therapeutics PTY LTD Therapeutic compounds
AU2008341010B2 (en) * 2007-12-21 2013-04-18 Certa Therapeutics Pty. Ltd. Halogenated analogues of anti-fibrotic agents
IN2012DN03312A (no) 2009-10-22 2015-10-23 Fibrotech Therapeutics Pty Ltd
WO2012012476A1 (en) * 2010-07-21 2012-01-26 Alcon Research, Ltd. Pharmaceutical composition with enhanced solubility characteristics
JP7191515B2 (ja) * 2017-01-17 2022-12-19 ロート製薬株式会社 眼科組成物
JP7185631B2 (ja) 2017-02-03 2022-12-07 サータ セラピューティクス プロプライエタリー リミテッド 抗線維化化合物
JP6427244B2 (ja) * 2017-10-03 2018-11-21 ロート製薬株式会社 点眼剤
TWI651095B (zh) * 2017-10-18 2019-02-21 晶碩光學股份有限公司 具有抗敏舒緩效果的眼用產品
CN109718376B (zh) * 2017-10-27 2022-01-25 晶硕光学股份有限公司 具有抗敏舒缓效果的眼用产品
EP3837238A1 (en) 2018-08-14 2021-06-23 Nuformix Technologies Limited Crystalline tranilast salts and their pharmaceutical use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1296518A (fr) * 1959-04-25 1962-06-22 Véhicule liquide pour collyre
US3856919A (en) * 1970-06-08 1974-12-24 Burton Parsons Chemicals Inc Ophthalmic solution
US4070484A (en) * 1973-01-18 1978-01-24 Kissei Pharmaceutical Co., Ltd. Antiallergic composition containing aromatic carboxylic amide derivatives and method of using the same
US4029817A (en) * 1973-09-24 1977-06-14 Allergan Pharmaceuticals Soft contact lens preserving solutions
JPS6144811A (ja) * 1984-08-10 1986-03-04 Ss Pharmaceut Co Ltd 徐放性ジクロフエナクナトリウム製剤
US4666929A (en) * 1985-04-10 1987-05-19 Shiseido Company Ltd. Anthranilic acid ester derivatives and antiinflammatory and analgetic external preparations containing the same
CA1291036C (en) * 1986-04-23 1991-10-22 Edwin I. Stoltz Nasal administration of drugs
EP0294493A4 (en) * 1986-12-25 1989-07-24 Teysan Pharmaceuticals Co Ltd SLOW DISSOLUTION GRANULE AND COMPOSITE GRANULE WITH PERSISTENT EFFECT PREPARED FROM THE FIRST GRANULE.
JPH01294620A (ja) * 1988-05-19 1989-11-28 Kissei Pharmaceut Co Ltd 水溶液製剤およびその製造方法

Also Published As

Publication number Publication date
FI895492A0 (fi) 1989-11-17
CA2003190C (en) 1997-04-29
EP0391002B1 (en) 1994-04-06
EP0391002A3 (en) 1991-06-26
ES2063146T3 (es) 1995-01-01
FI95773B (fi) 1995-12-15
NO176346B (no) 1994-12-12
US5356620A (en) 1994-10-18
DE68914438T2 (de) 1994-07-28
DK555089D0 (da) 1989-11-07
AU4438489A (en) 1990-10-11
DE68914438D1 (de) 1994-05-11
HK1003780A1 (en) 1998-11-06
EP0391002A2 (en) 1990-10-10
JPH02264716A (ja) 1990-10-29
NO176346C (no) 1995-03-22
KR940002660B1 (ko) 1994-03-28
CA2003190A1 (en) 1990-10-04
KR900015722A (ko) 1990-11-10
ATE103808T1 (de) 1994-04-15
NO894602L (no) 1990-10-05
DK555089A (da) 1990-10-05
FI95773C (fi) 1996-03-25
AU623191B2 (en) 1992-05-07
JPH07116029B2 (ja) 1995-12-13

Similar Documents

Publication Publication Date Title
NO894602D0 (no) Farmasoeytisk blanding inneholdende n-(3,4-dimetoksy-cinnamoyl)antranilsyre.
FI901421A0 (fi) N-(3-hydroxi-4-piperidinyl) (dihydrobenzofuran, dihydro-2h-benzopyran- eller dihydrobenzodioxin) karboxiamidderivat.
PH25504A (en) Novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides pharmaceutical composition containing said compound, method of use thereof